{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:44:20Z","timestamp":1793745860029,"version":"4.6.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.humpath.2023.10.003","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T11:26:50Z","timestamp":1700047610000},"page":"42-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Assessment of PD-L1, TROP2, and nectin-4 expression in penile squamous cell carcinoma"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2330-1215","authenticated-orcid":false,"given":"Burak","family":"Tekin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Cheville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren","family":"Herrera Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Negron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carin Y.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surendra","family":"Dasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Ann L.","family":"Enninga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Norgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio L.","family":"Cubilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumeal D.","family":"Whaley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael E.","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Houston","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley C.","family":"Leibovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Jeffrey","family":"Karnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Boorjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance C.","family":"Pagliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori A.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5163-6955","authenticated-orcid":false,"given":"Sounak","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2023.10.003_bib1","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1002\/cam4.4614","article-title":"Get insight into the cause of death distribution and epidemiology of penile squamous cell carcinoma: a population-based study","volume":"11","author":"Zhan","year":"2022","journal-title":"Cancer Med"},{"key":"10.1016\/j.humpath.2023.10.003_bib2","doi-asserted-by":"crossref","DOI":"10.2196\/34874","article-title":"Global pattern and trends in penile cancer incidence: population-based study","volume":"8","author":"Fu","year":"2022","journal-title":"JMIR Public Health Surveill"},{"key":"10.1016\/j.humpath.2023.10.003_bib3","article-title":"Evaluation of programmed cell death ligand 1 expression in a contemporary cohort of penile squamous cell carcinoma and its correlation with clinicopathologic and survival parameters: a study of 134 patients","author":"Lobo","year":"2023","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2023.10.003_bib4","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.juro.2016.09.088","article-title":"Expression of programmed death ligand 1 in penile cancer is of prognostic value and associated with HPV status","volume":"197","author":"Ottenhof","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2023.10.003_bib5","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/annonc\/mdw216","article-title":"Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches","volume":"27","author":"Udager","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2023.10.003_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.615298","article-title":"Case report: two cases of chemotherapy refractory metastatic penile squamous cell carcinoma with extreme durable response to pembrolizumab","volume":"10","author":"Chahoud","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.humpath.2023.10.003_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euros.2022.12.008","article-title":"An analysis of nectin-4 (PVRL4) in penile squamous cell carcinoma","volume":"49","author":"Grass","year":"2023","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.humpath.2023.10.003_bib8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41585-022-00617-x","article-title":"Immune-based therapies in penile cancer","volume":"19","author":"Joshi","year":"2022","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.humpath.2023.10.003_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djad155","article-title":"Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors","author":"El Zarif","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2023.10.003_bib10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/PAI.0000000000000938","article-title":"Expression of nectin-4 in bladder urothelial carcinoma, in morphologic variants, and nonurothelial histotypes","volume":"29","author":"Hoffman-Censits","year":"2021","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2023.10.003_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.874213","article-title":"Immunotherapy in penile squamous cell carcinoma: present or future? Multi-target analysis of programmed cell death ligand 1 expression and microsatellite instability","volume":"9","author":"Montella","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.humpath.2023.10.003_bib12","unstructured":"PD-L1 IHC 22C3 pharmDx Interpretation Manual \u2013 Urothelial Carcinoma. https:\/\/www.agilent.com\/cs\/library\/usermanuals\/public\/29276_22C3_pharmdx_uc_interpretation_manual_us.pdf [accessed 1 September 2023]."},{"key":"10.1016\/j.humpath.2023.10.003_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.humpath.2016.09.003","article-title":"Immune-checkpoint status in penile squamous cell carcinoma: a North American cohort","volume":"59","author":"Cocks","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2023.10.003_bib14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.euo.2018.07.010","article-title":"PD-L1 expression in men with penile cancer and its association with clinical outcomes","volume":"2","author":"Davidsson","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.humpath.2023.10.003_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1013806","article-title":"PD-L1 is associated with the prognosis of penile cancer: a systematic review and meta-analysis","volume":"12","author":"Lu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.humpath.2023.10.003_bib16","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1016\/j.clgc.2019.10.014","article-title":"PD-L1 and p16 expression in penile squamous cell carcinoma from an endemic region","volume":"18","author":"De Bacco","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.humpath.2023.10.003_bib17","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3390\/cancers12071796","article-title":"Immunophenotypes based on the tumor immune microenvironment allow for unsupervised penile cancer patient stratification","volume":"12","author":"Chu","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.humpath.2023.10.003_bib18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12094-021-02694-7","article-title":"The peri- and intratumoral immune cell infiltrate and PD-L1 status in invasive squamous cell carcinomas of the penis","volume":"24","author":"M\u00fcller","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.humpath.2023.10.003_bib19","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.urolonc.2020.04.015","article-title":"A nomogram incorporating PD-L1, NLR, and clinicopathologic features to predict inguinal lymph node metastasis in penile squamous cell carcinoma","volume":"38","author":"Hu","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.humpath.2023.10.003_bib20","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1269047","article-title":"Tumor PD-L1 expression is correlated with increased TILs and poor prognosis in penile squamous cell carcinoma","volume":"6","author":"Deng","year":"2017","journal-title":"OncoImmunology"},{"key":"10.1016\/j.humpath.2023.10.003_bib21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/CJI.0000000000000221","article-title":"Evidence for efficacy of treatment with the anti-PD-1 Mab nivolumab in radiation and multichemorefractory advanced penile squamous cell carcinoma","volume":"41","author":"Trafalis","year":"2018","journal-title":"J Immunother"},{"key":"10.1016\/j.humpath.2023.10.003_bib22","article-title":"Phase 2 study of pembrolizumab in patients with advanced rare cancers","volume":"8","author":"Aung","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.humpath.2023.10.003_bib23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/(SICI)1097-0215(19980529)76:5<671::AID-IJC10>3.0.CO;2-7","article-title":"Human Trop-2 is a tumor-associated calcium signal transducer","volume":"76","author":"Ripani","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2023.10.003_bib24","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.21037\/atm-22-5976","article-title":"A literature review of the promising future of TROP2: a potential drug therapy target","volume":"10","author":"Wen","year":"2022","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.humpath.2023.10.003_bib25","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.prp.2018.07.017","article-title":"High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma","volume":"214","author":"Tang","year":"2018","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.humpath.2023.10.003_bib26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000522206","article-title":"Trophoblast cell surface antigen 2 expression in human tumors: a tissue microarray study on 18,563 tumors","volume":"89","author":"Dum","year":"2022","journal-title":"Pathobiology"},{"key":"10.1016\/j.humpath.2023.10.003_bib27","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1186\/s12885-020-07257-7","article-title":"Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.humpath.2023.10.003_bib28","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/hed.23138","article-title":"Potential therapeutic target and independent prognostic marker of TROP2 in laryngeal squamous cell carcinoma","volume":"35","author":"Wu","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.humpath.2023.10.003_bib29","first-page":"1391","article-title":"Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs' development","volume":"128","author":"Moretto","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2023.10.003_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-27093-y","article-title":"Correlation of TROP-2 expression with clinical-pathological characteristics and outcome in triple-negative breast cancer","volume":"12","author":"Izci","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.humpath.2023.10.003_bib31","doi-asserted-by":"crossref","first-page":"8235","DOI":"10.1007\/s00432-023-04761-8","article-title":"TROP-2 is widely expressed in vulvar squamous cell carcinoma and represents a potential new therapeutic target","volume":"149","author":"Condic","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.humpath.2023.10.003_bib32","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2147\/CCID.S299862","article-title":"The role of TROP2 in BCC and cutaneous SCC: a clinical and immunohistochemical study","volume":"14","author":"Farag","year":"2021","journal-title":"Clin Cosmet Invest Dermatol"},{"key":"10.1016\/j.humpath.2023.10.003_bib33","doi-asserted-by":"crossref","first-page":"e1133","DOI":"10.1038\/cddis.2014.96","article-title":"Loss of TACSTD2 contributed to squamous cell carcinoma progression through attenuating TAp63-dependent apoptosis","volume":"5","author":"Wang","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.humpath.2023.10.003_bib34","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/hep4.1242","article-title":"Down-regulation of TROP-2 predicts poor prognosis of hepatocellular carcinoma patients","volume":"2","author":"Sin","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.humpath.2023.10.003_bib35","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa1814213","article-title":"Sacituzumab govitecan-hziy in refractory metastatic triple-negative breast cancer","volume":"380","author":"Bardia","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2023.10.003_bib36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.21037\/atm-22-621","article-title":"The anti-Trop-2 antibody-drug conjugate Sacituzumab Govitecan-effectiveness, pitfalls and promises","volume":"10","author":"Guerra","year":"2022","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.humpath.2023.10.003_bib37","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.18632\/oncotarget.28299","article-title":"Nectin-4 is widely expressed in head and neck squamous cell carcinoma","volume":"13","author":"Sanders","year":"2022","journal-title":"Oncotarget"},{"issue":"23","key":"10.1016\/j.humpath.2023.10.003_bib38","article-title":"Metastatic bladder cancer expression and subcellular localization of nectin-4 and Trop-2 in variant histology: a rapid autopsy study","volume":"7673","author":"Ghali","year":"2023","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.humpath.2023.10.003_bib39","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s11864-022-00940-w","article-title":"Nectin-4: a novel therapeutic target for skin cancers","volume":"23","author":"Hashimoto","year":"2022","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.humpath.2023.10.003_bib40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3390\/biomedicines9040355","article-title":"Nectin cell adhesion molecule 4 (NECTIN4) expression in cutaneous squamous cell sarcinoma: a new therapeutic target?","volume":"9","author":"Tanaka","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.humpath.2023.10.003_bib41","series-title":"AJCC cancer staging manual","first-page":"709","author":"Pettaway","year":"2018"},{"key":"10.1016\/j.humpath.2023.10.003_bib42","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/PAS.0b013e3181641365","article-title":"Histologic grade and perineural invasion are more important than tumor thickness as predictor of nodal metastasis in penile squamous cell carcinoma invading 5 to 10 mm","volume":"32","author":"Velazquez","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.10.003_bib43","series-title":"WHO classification of tumours editorial board. Urinary and male genital tumours","article-title":"Tumours of the penis and scrotum","author":"Chapter","year":"2022"},{"key":"10.1016\/j.humpath.2023.10.003_bib44","series-title":"Armed Forces Institute of pathology (AFIP)","first-page":"405e612","article-title":"Tumors of the prostate gland, seminal vesicles, penis, and scrotum","author":"Cubilla","year":"2020"},{"key":"10.1016\/j.humpath.2023.10.003_bib45","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/PAS.0b013e3181c76a49","article-title":"The basaloid cell is the best tissue marker for human papillomavirus in invasive penile squamous cell carcinoma: a study of 202 cases from Paraguay","volume":"34","author":"Cubilla","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.10.003_bib46","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.humpath.2022.12.012","article-title":"Penile squamous cell carcinoma exclusive to the shaft, with a proposal for a novel staging system","volume":"134","author":"Tekin","year":"2023","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2023.10.003_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154416","article-title":"The prognostic significance of Nectin-2 and Nectin-4 expression in glial tumors","volume":"244","author":"Dekani\u0107","year":"2023","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.humpath.2023.10.003_bib48","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.euo.2021.11.005","article-title":"TROP2 expression across molecular subtypes of urothelial carcinoma and enfortumab vedotin-resistant cells","volume":"5","author":"Chou","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.humpath.2023.10.003_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2021.10.009","article-title":"Human papillomavirus\u2012positive and \u2012negative vulvar squamous cell carcinoma are biologically but not clinically distinct","volume":"142","author":"Kolitz","year":"2022","journal-title":"J Invest Dermatol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817723002095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817723002095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:42:15Z","timestamp":1758645735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817723002095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":49,"alternative-id":["S0046817723002095"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2023.10.003","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of PD-L1, TROP2, and nectin-4 expression in penile squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2023.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}